One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1463-1326|1462-8902|10|965-973

ISSN: 1462-8902

Source: DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.1462-8902, Iss.10, 2015-10, pp. : 965-973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content